Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  McNagny, S. E.
space
  arrow  Frank, E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Personal Use of Postmenopausal Hormone Replacement Therapy by Women Physicians in the United States

right arrow Sally E. McNagny, MD, MPH; Nanette Kass Wenger, MD; and Erica Frank, MD, MPH

15 December 1997 | Volume 127 Issue 12 | Pages 1093-1096

Background: Women physicians' use of postmenopausal hormone replacement therapy (HRT) is unknown.

Objective: To study use of HRT by women physicians in the United States.

Design: Stratified random-sample mail survey.

Setting: United States.

Participants: 1466 postmenopausal women U.S. physicians in the Women Physicians' Health Study.

Measurements: Self-reported personal use of HRT and information on demographic, professional, and behavioral characteristics and medical history.

Results: Overall, 47.4% of participants currently use HRT; the prevalence of use is 59.8% in women 40 to 49 years of age, 49.4% in women 50 to 59 years of age, and 36.4% in women 60 to 70 years of age (P < 0.001). In an adjusted logistic regression model, current users were significantly more likely to be gynecologists, to be younger, to be white, to be sexually active, to be previous users of oral contraceptives, to live in Pacific or Mountain states, to have had a hysterectomy, and to have no personal or family history of breast cancer.

Conclusions: Women physicians have a higher rate of HRT use than that reported in cross-sectional U.S. surveys. This may presage greater use of HRT for U.S. women in the future.

Author and Article Information
space

From Emory University School of Medicine, Atlanta, Georgia.
Acknowledgments: The authors thank Brooke Fielding, MS, for statistical support and Dorothy Fitzmaurice for data management.
Grant Support: In part by grants from the American Medical Association's Education and Research Foundation, the American Heart Association (#95004090), a National Institutes of Health (National Heart, Lung, and Blood Institute) National Research Service Award (#5T32-HL-07034), the Emory Medical Care Foundation, and unrestricted grants from Wyeth-Ayerst and Solvay Pharmaceuticals.
Requests for Reprints: Sally E. McNagny, MD, MPH, Division of General Medicine, Emory University School of Medicine, 69 Butler Street, Atlanta, GA 30303.
Current Author Addresses: Dr. McNagny: Division of General Medicine, Emory University School of Medicine, 69 Butler Street, Atlanta, GA 30303.




This article has been cited by other articles:


Home page
J Natl Cancer Inst MonogrHome page
F. Wei, D. L. Miglioretti, M. T. Connelly, S. E. Andrade, K. M. Newton, C. L. Hartsfield, K. A. Chan, and D. S. M. Buist
Changes in Women's Use of Hormones After the Women's Health Initiative Estrogen and Progestin Trial by Race, Education, and Income
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
N. J Coombs, R. Taylor, N. Wilcken, and J. Boyages
Hormone replacement therapy and breast cancer: estimate of risk
BMJ, August 6, 2005; 331(7512): 347 - 349.
[Full Text] [PDF]


Home page
Arch SurgHome page
E. S. Hwang, T. Chew, S. Shiboski, G. Farren, C. C. Benz, and M. Wrensch
Risk Factors for Estrogen Receptor-Positive Breast Cancer
Arch Surg, January 1, 2005; 140(1): 58 - 62.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
J. P Vandenbroucke
Commentary: Treatment of bladder stones and probabilistic reasoning in medicine: an 1835 account and its lessons for the present
Int. J. Epidemiol., December 1, 2001; 30(6): 1253 - 1258.
[Full Text] [PDF]


Home page
Hum ReprodHome page
T. E. C. Workshop Group
Continuation rates for oral contraceptives and hormone replacement therapy
Hum. Reprod., August 1, 2000; 15(8): 1865 - 1871.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
N. Acs, Z. Vajo, Z. Miklos, G. Siklósi, F. Paulin, and B. Szekacs
Postmenopausal Hormone Replacement Therapy and Cardiovascular Mortality in Central-Eastern Europe
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 160M - 162.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
N. L. Keating, P. D. Cleary, A. S. Rossi, A. M. Zaslavsky, and J. Z. Ayanian
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Ann Intern Med, April 6, 1999; 130(7): 545 - 553.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1997 by the American College of Physicians.